FDA Device recall Z-0267-2018
I-125 CE Marked QuickLink Cartridges
- FDA Device
- Class II
- terminated
- Published 2017-12-27
On 2017-12-27 the FDA classified a Class II recall of I-125 CE Marked QuickLink Cartridges by C R Bard, citing activity and quantity of seeds sent in shipments were incorrect.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-0267-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-12-09 |
| Published | 2017-12-27 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | C R Bard |
| Distribution | n/a |
Product
I-125 CE Marked QuickLink Cartridges; Sterile; Bard Brachysource Radioactive Seeds in QuickLink Cartridges Indicated for permanent interstitial treatment of selected localized tumors such as: head and neck, lung, pancreas, and early stage prostate. Implants are indicated to treat residual tumors following completion of a course of external radiation therapy and for recurrent tumors.
Reason
Activity and quantity of seeds sent in shipments were incorrect.
Identifiers
| code_info | Product Code: 1251QCSCE, Lot No. BBAY0072, BBAY0079, BBAY0090, BBAY0071, BBAY0073. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0267-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.